Evidence map›Paper›PMID 37817770›Full record

ArticleFrontiers in oncology2023

Single-cell RNA sequencing of neurofibromas reveals a tumor microenvironment favorable for neural regeneration and immune suppression in a neurofibromatosis type 1 porcine model.

Dalton T McLean, Jennifer J Meudt, Loren D Lopez Rivera, Dominic T Schomberg, Derek M Pavelec, Tyler T Duellman, Darya G Buehler, Patrick B Schwartz, Melissa Graham, Laura M Lee and 7 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 1 institution in 1 country.

Dalton T McLeanBiotechnology Center, University of Wisconsin-Madison, Madison, WI, United States.
Jennifer J MeudtBiomedical & Genomic Research Group, Department of Animal and Dairy Sciences, University of Wisconsin-Madison, Madison, WI, United States.
Loren D Lopez RiveraMolecular & Environmental Toxicology Program, University of Wisconsin-Madison, Madison, WI, United States.
Dominic T SchombergBiomedical & Genomic Research Group, Department of Animal and Dairy Sciences, University of Wisconsin-Madison, Madison, WI, United States.
Derek M PavelecBiotechnology Center, University of Wisconsin-Madison, Madison, WI, United States.
Tyler T DuellmanBiotechnology Center, University of Wisconsin-Madison, Madison, WI, United States.
Darya G BuehlerDepartment of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States.
Patrick B SchwartzMolecular & Environmental Toxicology Program, University of Wisconsin-Madison, Madison, WI, United States.
Melissa GrahamResearch Animal Resources and Compliance (RARC), Office of the Vice Chancellor for Research and Graduate Education, University of Wisconsin-Madison, Madison, WI, United States.
Laura M LeeResearch Animal Resources and Compliance (RARC), Office of the Vice Chancellor for Research and Graduate Education, University of Wisconsin-Madison, Madison, WI, United States.
Keri D GraffSwine Research and Teaching Center, Department of Animal and Dairy Sciences, University of Wisconsin-Madison, Madison, WI, United States.
Jamie L ReichertSwine Research and Teaching Center, Department of Animal and Dairy Sciences, University of Wisconsin-Madison, Madison, WI, United States.
Sandra S Bon-DurantBiotechnology Center, University of Wisconsin-Madison, Madison, WI, United States.
Charles M KonsitzkeBiotechnology Center, University of Wisconsin-Madison, Madison, WI, United States.
Sean M Ronnekleiv-KellyDepartment of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, United States.
Dhanansayan ShanmuganayagamMolecular & Environmental Toxicology Program, University of Wisconsin-Madison, Madison, WI, United States.
C Dustin RubinsteinBiotechnology Center, University of Wisconsin-Madison, Madison, WI, United States.
University of Wisconsin–Madison · US

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Justine Yang Bruce · 1985 to 2026
$142.6M
Molecular & Environmental Toxicology Pre-& Postdoctoral Training ProgramT32ES007015 · NIEHS · UNIVERSITY OF WISCONSIN-MADISON · PI CHRISTOPHER A BRADFIELD · 1985 to 2026
$11.5M
NCI NIH HHS P30 CA014520NIEHS NIH HHS T32 ES007015
6 · The paper itself

Abstract

Neurofibromatosis Type 1 (NF1) is one of the most common genetically inherited disorders that affects 1 in 3000 children annually. Clinical manifestations vary widely but nearly always include the development of cutaneous, plexiform and diffuse neurofibromas that are managed over many years. Recent single-cell transcriptomics profiling efforts of neurofibromas have begun to reveal cell signaling processes. However, the cell signaling networks in mature, non-cutaneous neurofibromas remain unexplored. Here, we present insights into the cellular composition and signaling within mature neurofibromas, contrasting with normal adjacent tissue, in a porcine model of NF1 using single-cell RNA sequencing (scRNA-seq) analysis and histopathological characterization. These neurofibromas exhibited classic diffuse-type histologic morphology and expected patterns of S100, SOX10, GFAP, and CD34 immunohistochemistry. The porcine mature neurofibromas closely resemble human neurofibromas histologically and contain all known cellular components of their human counterparts. The scRNA-seq confirmed the presence of all expected cell types within these neurofibromas and identified novel populations of fibroblasts and immune cells, which may contribute to the tumor microenvironment by suppressing inflammation, promoting M2 macrophage polarization, increasing fibrosis, and driving the proliferation of Schwann cells. Notably, we identified tumor-associated

Indexed as

cancer-associated fibroblasts (CAF)immune checkpointneurofibromaneurofibromatosis type 1 (NF1)neuroregenerationsingle cell RNA seqswinetumor microenvironment (TME)

Identifiers

PMID37817770
PMCPMC10561395
OpenAlexW4387056425

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.